- Belgrade '18
- Vienna '18
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: AliFadlallah LEBANON
Co Author(s): Ali Dirani Elias Chelala Rafic Antonios George Cherfan Elias Jarade
Back to previous
To evaluate the safety and clinical outcome of combined non-topo-guided photorefractive Keratectomy (NTG-PRK) and corneal collagen cross-linking (CXL) for the treatment of mild refractive errors in patients with early stage keratoconus.
: Beirut Eye Specialist Hospital, beirut, lebanon
A retrospective study examined the records of patients with early stage keratoconus (forme fruste or stage 1 or 2) who underwent NTG-PRK and CXL. The two procedures were performed at the same day at Beirut Eye speciality Hospital. Data were collected preoperatively, at the 6-month follow-up visit after combined NTG-PRK/CXL, and at 1 year and 2 years follow up visits.
79 patients (140 eyes) were included in the study. All patients had at least 2 years follow-up. Combined NTG-PRK and CXL induced a significant increase in visual acuity and decrease in refraction. Uncorrected distance visual acuity (UCVA) significantly improved from 0.45±0.18 logMAR before Combined NTG-PRK/CXL to 0.78±0.17 logMAR at last follow up visit (p <0.001) and corrected distance visual acuity (CDVA) remained stable (0.035±0.062 logMAR preoperatively vs 0.036±0.058 logMAR postoperatively, p=0.79). The mean spherical equivalence decreased from -1.78±1.43 D to -0.42±0.60 D (p <0.001), and the mean cylinder from 1.47±1.10D to 0.83±0.55D (p <0.001). At last follow up visit mean Kflat was 45.62±1.72D vs. 43.30±1.75D preoperatively (p=0.03) and mean Ksteep was 46.53±2.13D vs. 44.39±3.14D preoperatively (p=0.02). No intraoperative complications occurred. Four eyes developed mild haze that responded well to a short course of topical steroids. No eye developed infectious keratitis.
Non topo-guided Photorefractive keratectomy combined to corneal collagen cross-linking is an effective and safe option for correcting mild refractive error and improving visual acuity in patients with early keratoconus. FINANCIAL INTEREST: NONE